Clarity Medical Group Holding Limited provided consolidated earnings guidance for the six months ended 30 September 2022. For the period, the company expects a decrease in profit attributable to owners of the Company in a range of approximately HKD 2.3 million to HKD 3.8 million for the Interim Period as compared to the same period in 2021, representing an expected drop of approximately 21% to 34%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5 HKD | +6.38% |
|
+2.04% | -20.63% |
05-29 | Clarity Medical Group Holding Limited Appoints Cheng Jessica as Independent Non-Executive Director and Audit Committee | CI |
05-24 | Clarity Medical to Widen Loss in Fiscal 2024 | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.63% | 31.82M | |
-26.36% | 14.93B | |
-1.80% | 11.81B | |
+3.65% | 11.67B | |
+8.83% | 10.68B | |
+26.35% | 8.49B | |
-8.06% | 7.3B | |
+6.02% | 6.72B | |
+9.84% | 6.48B | |
+19.81% | 4.54B |
- Stock Market
- Equities
- 1406 Stock
- News Clarity Medical Group Holding Limited
- Clarity Medical Group Holding Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 September 2022